Antiretroviral Regimen Adherence Up for Americans With HIV

Share this content:
Antiretroviral Regimen Adherence Up for Americans With HIV
Antiretroviral Regimen Adherence Up for Americans With HIV

THURSDAY, June 1, 2017 (HealthDay News) -- More Americans with HIV are adhering to antiretroviral therapy regimens, according to a study published online May 16 in AIDS.

Bora Youn, of the Brown University School of Public Health in Providence, R.I., and colleagues analyzed data for 43,598 Medicaid patients in 14 states from 2001 to 2010.

In 2001 to 2003, half of patients stopped taking HIV medications 23.9 months after starting them, but that rose to 35.4 months by 2004 to 2006. More than half of the patients were still taking the medications by 2007 to 2010, the end of the study period, the researchers reported. However, women, blacks, and individuals living in certain states (e.g., Louisiana and Texas) remained more likely to discontinue therapy sooner than men, whites, and people living in other states (e.g., Maryland and New Jersey).

While there have been significant increases in how long HIV patients take their medications, many still stop taking the drugs after a few years, the researchers cautioned. "Although it is improving, it is still not optimal," Youn said in a university news release. "Many people discontinue therapy in a short period of time." Reasons why HIV patients stop taking their medications include cost, side effects, and stigma, according to the researchers.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths